Corticosteroid-Eluting Sinus Stents tied to post operative infections, Finds study

The following were results reported-

a. There were 28 reported adverse events in total, with all events being related to the Propel family of stents and none related to Sinuva stents.

b. Overall, 22 were categorized as patient-related adverse events and 6 as device-related events.

c. The most common adverse event was related to postoperative infection, accounting for 39% (n = 11) of all complications.

d. Four of these patients developed periorbital cellulitis, and 5 developed a fungal infection.

e. The second-most common adverse event was migration of the stent, representing 21% of all complications (n = 6).

f. Overall, 8 patients (29%) in our cohort required reintervention in the operating room, with subsequent removal of the CES.

Hence, it was concluded that "The most commonly reported adverse events were postoperative infection, including multiple cases of fungal infection, followed by migration of the stent."

However, an increased awareness of the complications associated with CESs can be used to better inform patients during the consenting process as well as surgeons in their surgical decision making, they said.